171 related articles for article (PubMed ID: 36460868)
1. Refurbishment of NK cell effector functions through their receptors by depleting the activity of nTreg cells in Dalton's Lymphoma-induced tumor microenvironment: an in vitro and in vivo study.
Tomar MS; Singh RK; Ulasov IV; Kaushalendra ; Acharya A
Cancer Immunol Immunother; 2023 Jun; 72(6):1429-1444. PubMed ID: 36460868
[TBL] [Abstract][Full Text] [Related]
2. NK Cell Effector Functions Regulation by Modulating nTreg Cell Population During Progressive Growth of Dalton's Lymphoma in Mice.
Tomar MS; Kumar S; Kumar S; Gautam PK; Singh RK; Verma PK; Singh SP; Acharya A
Immunol Invest; 2018 Jan; 47(1):40-56. PubMed ID: 28891726
[TBL] [Abstract][Full Text] [Related]
3. Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
Bergmann C; Wild CA; Narwan M; Lotfi R; Lang S; Brandau S
Eur J Immunol; 2011 Dec; 41(12):3564-73. PubMed ID: 21905023
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
6. Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D.
Wang Z; Guo L; Song Y; Zhang Y; Lin D; Hu B; Mei Y; Sandikin D; Liu H
Cancer Immunol Immunother; 2017 Apr; 66(4):537-548. PubMed ID: 28184969
[TBL] [Abstract][Full Text] [Related]
7. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
Zhou H; Chen L; You Y; Zou L; Zou P
Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.
Chang WC; Li CH; Chu LH; Huang PS; Sheu BC; Huang SC
Int J Gynecol Cancer; 2016 Jan; 26(1):156-62. PubMed ID: 26512789
[TBL] [Abstract][Full Text] [Related]
9. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
11. Control of NK cell functions by CD4+CD25+ regulatory T cells.
Ralainirina N; Poli A; Michel T; Poos L; Andrès E; Hentges F; Zimmer J
J Leukoc Biol; 2007 Jan; 81(1):144-53. PubMed ID: 16959895
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.
Jie HB; Schuler PJ; Lee SC; Srivastava RM; Argiris A; Ferrone S; Whiteside TL; Ferris RL
Cancer Res; 2015 Jun; 75(11):2200-10. PubMed ID: 25832655
[TBL] [Abstract][Full Text] [Related]
13. Cord blood CD4(+)CD25(+) regulatory T cells fail to inhibit cord blood NK cell functions due to insufficient production and expression of TGF-beta1.
Xu L; Tanaka S; Bonno M; Ido M; Kawai M; Yamamoto H; Komada Y
Cell Immunol; 2014 Jul; 290(1):89-95. PubMed ID: 24950027
[TBL] [Abstract][Full Text] [Related]
14. CCR4 mediated chemotaxis of regulatory T cells suppress the activation of T cells and NK cells via TGF-β pathway in human non-small cell lung cancer.
Liu W; Wei X; Li L; Wu X; Yan J; Yang H; Song F
Biochem Biophys Res Commun; 2017 Jun; 488(1):196-203. PubMed ID: 28487109
[TBL] [Abstract][Full Text] [Related]
15. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
[TBL] [Abstract][Full Text] [Related]
16. Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.
Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
Cancer Immunol Res; 2018 Jul; 6(7):766-775. PubMed ID: 29784636
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa Infection Impairs NKG2D-Dependent NK Cell Cytotoxicity through Regulatory T-Cell Activation.
Vourc'h M; David G; Gaborit B; Broquet A; Jacqueline C; Chaumette T; Caillon J; Roquilly A; Retiere C; Asehnoune K
Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32928966
[TBL] [Abstract][Full Text] [Related]
18. Association of peripheral NK cell counts with Helios
Trojan K; Zhu L; Aly M; Weimer R; Bulut N; Morath C; Opelz G; Daniel V
Clin Exp Immunol; 2017 Jun; 188(3):467-479. PubMed ID: 28194759
[TBL] [Abstract][Full Text] [Related]
19. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
20. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
